For Healthcare Professionals

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

clipboard-pencil

About the study

The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Inclusion Criteria:

  1. Patients 18 years and older
  2. Written informed consent (patient data release-form)
  3. Use of any commercially available Boston Scientific drug-eluting device marketed for treatment of lesions in the peripheral vasculature and specified in the Registry Enrollment Guide

EXCLUSION CRITERIA

Exclusion Criteria:

Life expectancy of <1 year

pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.

Study’s details


Contition

Peripheral Vascular Diseases

Age (in years)

18+

Participants needed

5000

Est. Completion Date

Jan 31, 2028

Treatment type

Observational [Patient Registry]


Sponsor

Boston Scientific Corporation

ClinicalTrials.gov identifier

NCT04674969

Study number

S2444

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.